Catalyst Wire Dossier Catalyst Wire Dossier

RIPE regimen (Rifampin/Isoniazid/Pyrazinamide/Ethambutol)

Rifampin; Isoniazid; Pyrazinamide; Ethambutol (RIPE) combination
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RIPE regimen (Rifampin/Isoniazid/Pyrazinamide/Ethambutol), covering 2019-02-15 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection [Phase 2]

See pricing